Island Pharmaceuticals Ltd
ASX:ILA
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| AU |
|
Island Pharmaceuticals Ltd
ASX:ILA
|
118.4m AUD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
948.8B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
563B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
286.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.6B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.1B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
224.1B CHF |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
98.2B EUR |
Loading...
|
Market Distribution
| Min | -16 177 900% |
| 30th Percentile | -544.7% |
| Median | -27.7% |
| 70th Percentile | 3.1% |
| Max | 3 174 540% |
Other Profitability Ratios
Island Pharmaceuticals Ltd
Glance View
Island Pharmaceuticals Ltd. is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-04-13. The firm focuses on developing preventative or therapeutic drugs for viral infections. Its lead product candidate ISLA-101, is a drug developed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. Its ISLA-101 is an antiviral oral drug to treat mosquito-borne viruses and is in Phase II of the clinical program.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Island Pharmaceuticals Ltd is -6 666.8%, which is above its 3-year median of -73 120.8%.
Over the last 3 years, Island Pharmaceuticals Ltd’s Net Margin has increased from -73 297.8% to -6 666.8%. During this period, it reached a low of -249 438.5% on Dec 31, 2024 and a high of -6 666.8% on Jul 30, 2025.
